Cargando…

Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross‐sectional and longitudinal analyses

OBJECTIVES: There is increasing evidence to suggest that people living with HIV (PLWH) have significant morbidity from alcohol, recreational drug use and cigarette smoking. Our aim was to report associations of these factors with antiretroviral therapy (ART) non‐adherence, viral non‐suppression and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Timothy P. W., Lampe, Fiona C., Arenas‐Pinto, Alejandro, Smith, Colette, McDonnell, Jeff, Haddow, Lewis, Johnson, Margaret, Yousef, Elaney, Lascar, Monica, Maria Geretti, Anna, Sherr, Lorraine, Collins, Simon, Phillips, Andrew N., Rodger, Alison J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293433/
https://www.ncbi.nlm.nih.gov/pubmed/34634176
http://dx.doi.org/10.1111/hiv.13156
_version_ 1784749630693572608
author Jones, Timothy P. W.
Lampe, Fiona C.
Arenas‐Pinto, Alejandro
Smith, Colette
McDonnell, Jeff
Haddow, Lewis
Johnson, Margaret
Yousef, Elaney
Lascar, Monica
Maria Geretti, Anna
Sherr, Lorraine
Collins, Simon
Phillips, Andrew N.
Rodger, Alison J.
author_facet Jones, Timothy P. W.
Lampe, Fiona C.
Arenas‐Pinto, Alejandro
Smith, Colette
McDonnell, Jeff
Haddow, Lewis
Johnson, Margaret
Yousef, Elaney
Lascar, Monica
Maria Geretti, Anna
Sherr, Lorraine
Collins, Simon
Phillips, Andrew N.
Rodger, Alison J.
author_sort Jones, Timothy P. W.
collection PubMed
description OBJECTIVES: There is increasing evidence to suggest that people living with HIV (PLWH) have significant morbidity from alcohol, recreational drug use and cigarette smoking. Our aim was to report associations of these factors with antiretroviral therapy (ART) non‐adherence, viral non‐suppression and subsequent viral rebound in PLWH. METHODS: The Antiretroviral Sexual Transmission Risk and Attitudes (ASTRA) study recruited PLWH attending eight outpatient clinics in England between February 2011 and December 2012. Data included self‐reported excessive drinking (estimated consumption of > 20 units of alcohol/week), alcohol dependency (CAGE score ≥ 2 with current alcohol consumption), recreational drug use (including injection drug use in the past 3 months), and smoking status. Among participants established on ART, cross‐sectional associations with ART non‐adherence [missing ≥2 consecutive days of ART on ≥2 occasions in the past three months] and viral‐non suppression [viral load (VL) > 50 copies/mL] were assessed using logistic regression. In participants from one centre, longitudinal associations with subsequent viral rebound (first VL > 200 copies/mL) in those on ART with VL ≤ 50 copies/mL at baseline were assessed using Cox regression during a 7‐year follow‐up. RESULTS: Among 3258 PLWH, 2248 (69.0%) were men who have sex with men, 373 (11.4%) were heterosexual men, and 637 (19.6%) were women. A CAGE score ≥ 2 was found in 568 (17.6%) participants, 325 (10.1%) drank > 20 units/week, 1011 (31.5%) currently smoked, 1242 (38.1%) used recreational drugs and 74 (2.3%) reported injection drug use. In each case, prevalence was much more common among men than among women. Among 2459 people on ART who started at least 6 months previously, a CAGE score ≥ 2, drinking > 20 units per week, current smoking, injection and non‐injection drug use were all associated with ART non‐adherence. After adjusting for demographic and socioeconomic factors, CAGE score ≥ 2 [adjusted odds ratio (aOR) = 1.52, 95% confidence interval (CI): 1.09–2.13], current smoking (aOR = 1.58, 95% CI: 1.10–2.17) and injection drug use (aOR = 2.11, 95% CI: 1.00–4.47) were associated with viral non‐suppression. During follow‐up of a subset of 592 people virally suppressed at recruitment, a CAGE score ≥ 2 [adjusted hazard ratio (aHR) = 1.66, 95% CI: 1.03–2.74], use of 3 or more non‐injection drugs (aHR = 1.82, 95% CI: 1.12–3.57) and injection drug use (aHR = 2.73, 95% CI: 1.08–6.89) were associated with viral rebound. CONCLUSIONS: Screening and treatment for alcohol, cigarette and drug use should be integrated into HIV outpatient clinics, while clinicians should be alert to the potential for poorer virological outcomes.
format Online
Article
Text
id pubmed-9293433
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92934332022-07-20 Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross‐sectional and longitudinal analyses Jones, Timothy P. W. Lampe, Fiona C. Arenas‐Pinto, Alejandro Smith, Colette McDonnell, Jeff Haddow, Lewis Johnson, Margaret Yousef, Elaney Lascar, Monica Maria Geretti, Anna Sherr, Lorraine Collins, Simon Phillips, Andrew N. Rodger, Alison J. HIV Med Original Research OBJECTIVES: There is increasing evidence to suggest that people living with HIV (PLWH) have significant morbidity from alcohol, recreational drug use and cigarette smoking. Our aim was to report associations of these factors with antiretroviral therapy (ART) non‐adherence, viral non‐suppression and subsequent viral rebound in PLWH. METHODS: The Antiretroviral Sexual Transmission Risk and Attitudes (ASTRA) study recruited PLWH attending eight outpatient clinics in England between February 2011 and December 2012. Data included self‐reported excessive drinking (estimated consumption of > 20 units of alcohol/week), alcohol dependency (CAGE score ≥ 2 with current alcohol consumption), recreational drug use (including injection drug use in the past 3 months), and smoking status. Among participants established on ART, cross‐sectional associations with ART non‐adherence [missing ≥2 consecutive days of ART on ≥2 occasions in the past three months] and viral‐non suppression [viral load (VL) > 50 copies/mL] were assessed using logistic regression. In participants from one centre, longitudinal associations with subsequent viral rebound (first VL > 200 copies/mL) in those on ART with VL ≤ 50 copies/mL at baseline were assessed using Cox regression during a 7‐year follow‐up. RESULTS: Among 3258 PLWH, 2248 (69.0%) were men who have sex with men, 373 (11.4%) were heterosexual men, and 637 (19.6%) were women. A CAGE score ≥ 2 was found in 568 (17.6%) participants, 325 (10.1%) drank > 20 units/week, 1011 (31.5%) currently smoked, 1242 (38.1%) used recreational drugs and 74 (2.3%) reported injection drug use. In each case, prevalence was much more common among men than among women. Among 2459 people on ART who started at least 6 months previously, a CAGE score ≥ 2, drinking > 20 units per week, current smoking, injection and non‐injection drug use were all associated with ART non‐adherence. After adjusting for demographic and socioeconomic factors, CAGE score ≥ 2 [adjusted odds ratio (aOR) = 1.52, 95% confidence interval (CI): 1.09–2.13], current smoking (aOR = 1.58, 95% CI: 1.10–2.17) and injection drug use (aOR = 2.11, 95% CI: 1.00–4.47) were associated with viral non‐suppression. During follow‐up of a subset of 592 people virally suppressed at recruitment, a CAGE score ≥ 2 [adjusted hazard ratio (aHR) = 1.66, 95% CI: 1.03–2.74], use of 3 or more non‐injection drugs (aHR = 1.82, 95% CI: 1.12–3.57) and injection drug use (aHR = 2.73, 95% CI: 1.08–6.89) were associated with viral rebound. CONCLUSIONS: Screening and treatment for alcohol, cigarette and drug use should be integrated into HIV outpatient clinics, while clinicians should be alert to the potential for poorer virological outcomes. John Wiley and Sons Inc. 2021-10-11 2022-03 /pmc/articles/PMC9293433/ /pubmed/34634176 http://dx.doi.org/10.1111/hiv.13156 Text en © 2021 The Authors. HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Jones, Timothy P. W.
Lampe, Fiona C.
Arenas‐Pinto, Alejandro
Smith, Colette
McDonnell, Jeff
Haddow, Lewis
Johnson, Margaret
Yousef, Elaney
Lascar, Monica
Maria Geretti, Anna
Sherr, Lorraine
Collins, Simon
Phillips, Andrew N.
Rodger, Alison J.
Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross‐sectional and longitudinal analyses
title Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross‐sectional and longitudinal analyses
title_full Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross‐sectional and longitudinal analyses
title_fullStr Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross‐sectional and longitudinal analyses
title_full_unstemmed Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross‐sectional and longitudinal analyses
title_short Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross‐sectional and longitudinal analyses
title_sort alcohol, smoking, recreational drug use and association with virological outcomes among people living with hiv: cross‐sectional and longitudinal analyses
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293433/
https://www.ncbi.nlm.nih.gov/pubmed/34634176
http://dx.doi.org/10.1111/hiv.13156
work_keys_str_mv AT jonestimothypw alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT lampefionac alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT arenaspintoalejandro alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT smithcolette alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT mcdonnelljeff alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT haddowlewis alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT johnsonmargaret alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT yousefelaney alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT lascarmonica alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT mariagerettianna alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT sherrlorraine alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT collinssimon alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT phillipsandrewn alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT rodgeralisonj alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses
AT alcoholsmokingrecreationaldruguseandassociationwithvirologicaloutcomesamongpeoplelivingwithhivcrosssectionalandlongitudinalanalyses